Comparison of Opioid Based and Opioid Free Anaesthesia in Transsphenoidal Surgery

Sponsor
Postgraduate Institute of Medical Education and Research (Other)
Overall Status
Completed
CT.gov ID
NCT03120234
Collaborator
(none)
60
1
2
11
5.5

Study Details

Study Description

Brief Summary

This study has been planned to compare the effect of opioid free anaesthesia using dexmedetomidine and ketamine with opioid based anaesthesia using fentanyl in maintaining the intraoperative hemodynamic stability and recovery characteristics in patients undergoing Transsphenoidal surgery of pituitary tumors.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

Opioid Free Anesthesia (OFA) is a technique where no intraoperative opioid is administered during the anesthetic management. Opioid free anesthesia is usually achieved through sympatholysis, analgesia, and anesthesia with dexmedetomidine and analgesia with low dose ketamine. In addition paracetamol and other non-steroidal anti inflammatory drugs (NSAIDS) may be used as adjuncts to the multi-modal pain regimen.

Dexmedetomidine, a highly selective agonist of the alpha2 adrenergic receptor, has many clinical benefits, such as sedation, analgesia, preventing unwanted stress responses and low risk of respiratory depression. Because of concern that opioids might cause perioperative respiratory depression, substitution with dexmedetomidine will be helpful with its analgesic and sympatholytic properties. Dexmedetomidine has shown to reduce minimum alveolar concentration (MAC) of inhalational anesthetics and the requirement of perioperative opioid by 30-50%. In neurosurgical patients, dexmedetomidine is helpful in maintaining intracranial pressure (ICP) and intraoperative hemodynamic stability, especially during intubation and extubation. It can allow for faster awakening and thus an earlier neurological examination by decreasing necessary volatile agent and opioid doses.

Ketamine, an N-methyl-d-aspartate(NMDA) antagonist, blunts central pain sensitization at sub-anesthetic doses (0.5 mg/kg or less) and has been studied extensively as an adjunct for perioperative analgesia. Sub-anesthetic ketamine improves pain scores and reduces perioperative opioid consumption in a broad range of surgical procedures.Recent literature has suggested that adjuvant ketamine administration in mechanically ventilated patients has no cerebrovascular effects.

The present study has been planned to compare the effect of opioid free anesthesia using dexmedetomidine and ketamine with opioid based anesthesia using fentanyl in maintaining the intraoperative hemodynamic stability and recovery characteristics in patients undergoing TSS of pituitary tumors.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Health Services Research
Official Title:
Comparison of Opioid Based and Opioid Free Anaesthesia in Transsphenoidal Surgery for Haemodynamic Stability and Recovery Characteristics
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Oct 1, 2017
Actual Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dexmedetomidine and ketamine

The group will receive loading dose of dexmedetomidine 1mcg/kg over 10 Min followed by a maintenance of 0.5 mcg/ kg/ hr.ketamine 0.5 mg/kg will be given as bolus at the time of induction.

Drug: Dexmedetomidine

Drug: Ketamine

Experimental: fentanyl and placebo

pts will receive fentanyl 2mcg/kg as bolus over 10 Mon followed by 1 mcg/ kg/hr as maintenance, instead of ketamine placebo(0.9%saline ) will be given in control group

Drug: Fentanyl

Drug: Placebos
o.9% normal saline will be used instead of ketamine

Outcome Measures

Primary Outcome Measures

  1. To measure the emerence and extubation times in both groups [15minutes]

    it is measured by noting the time for emergence and extubation after stopping inhalational anaesthesia.

  2. to measure the level of emergence in both the groups [15min]

    using Riker sedation-agitation score

  3. to measure the level of cognition in both the groups [15min]

    using Short orientation memory concentration test (SOMC test)

Secondary Outcome Measures

  1. comparison of intraoperative hemodynamic stability in both the groups [intra operative period]

    this will be done by monitoring intraoperative hemodynamics and noting down no of events of hypotension and hypertension and noting down the rescue drug requirements.

  2. postoperative pain assessment by using numeric rating scale [24 hrs]

  3. comparing postoperative analgesic dose requirement in both the groups [24hrs]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • patients suffering significant pituitary adenocarcinomas posted for transsphenoidal resection of tumor

  • age group between 18 to 65 yr

  • Both males and females

  • ASA physical status 1 to 2

Exclusion Criteria:
  • pts taking opioid for chronic pain

  • Pregnant or nursing woman

  • Preoperative GCS <15

  • HR<50/min

  • Patients with allergies to study medication

  • Patients with psychiatric disorder

  • Patients with unstable cardiorespiratory disorder

  • Patients with hepatic and renal insufficiency

Contacts and Locations

Locations

Site City State Country Postal Code
1 Post graduation institute of medical education and research Chandigarh India 160012

Sponsors and Collaborators

  • Postgraduate Institute of Medical Education and Research

Investigators

  • Principal Investigator: AYYAWAR HAREESH, MBBS, Post Graduate Institute of Medical Education and Research

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ayyawar Hareesh, principal investigator, Postgraduate Institute of Medical Education and Research
ClinicalTrials.gov Identifier:
NCT03120234
Other Study ID Numbers:
  • MK/2950/MD/13121
First Posted:
Apr 19, 2017
Last Update Posted:
Jul 8, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2019